in the medical technology space. Our Orthopaedics division focuses on delivering cutting-edge products and technologies... modeling, to support product value propositions. Collaborate with cross-functional teams, including marketing, medical affairs...
and interpretation by medical staff. Maintain and advance own clinical competence and participates on committees/teams and approved... class innovator in medical care, research and teaching, delivering service to more than one million BC residents. At VCH...
for a 0.7 FTE Medical Radiation Tech II to join our dedicated team. Reporting directly to the CT Supervisor, the..., equipment operation, and strong leadership through collaboration with interdisciplinary teams. As a Medical Radiation Tech II...
which guide our individual behaviours and attitudes. Current registration with the College of Medical Laboratory Technologists... will be required to provide proof of vaccination or proof of a documented medical exemption as part of the hiring process. All personal...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »